(Total Views: 282)
Posted On: 09/26/2022 9:43:42 AM
Post# of 1418
Not sure this would be apparent to new investors but...
You may want to interrupt the sentence below to say most of the things forsale in the machine, Todos will get 100% of their cut which is around $12 an item. I would imagine only for Tollovid products, profit would be split 52%. So most of the revenue & profit will be Todos. This cash cow will enable Todos to move from cash flow positive to highly profitable with high revenue. The best part is, machine installs start in a month. Not a year from now or some far off timeline. Somewhere between now and then, the market will figure it out.
You may want to interrupt the sentence below to say most of the things forsale in the machine, Todos will get 100% of their cut which is around $12 an item. I would imagine only for Tollovid products, profit would be split 52%. So most of the revenue & profit will be Todos. This cash cow will enable Todos to move from cash flow positive to highly profitable with high revenue. The best part is, machine installs start in a month. Not a year from now or some far off timeline. Somewhere between now and then, the market will figure it out.
Quote:
Gerald Commissiong@G_Commish 3h
The machine will be full of a variety of products most without Tollovid. We manufacture those as well. So the facility does CBD now and we will be adding Tollovid to it. We expect somewhere around a 30% monthly turnover although $50M is at 5%.
At 30% turnover that would be $31,680,000 for the initial stock and...
$9,504,000 a month
So ongoing beyond the $31M, $114M a year
(1)
(0)
